FibroGen Company

FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs.
Technology: Regenerative medicine
Industry: Regenerative Medicine
Headquarters: San Francisco
Founded Date: 1993
Employees Number: 251-500
Funding Status: IPO

Visit Website
info@fibrogen.com
Register and Claim Ownership